TrialBritish journal of haematology2019
Venetoclax and hypomethylating agents in TP53-mutated acute myeloid leukaemia.
Ibrahim Aldoss et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
31 papers cite it
this papercites it
TrialBritish journal of haematology2019
Ibrahim Aldoss et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.